564 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
Rank Status Study
1 Recruiting Mediterranean Diet Versus Hypocaloric Diet in PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Other: mediterranean diet, restricted calorie;   Other: hypocaloric diet, restricted calorie
2 Recruiting Mediterranean Diet as Treatment for Normal Weight Women With PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Other: mediterranean diet;   Other: normocaloric diet
3 Recruiting Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer
Intervention: Drug: BIBF 1120
4 Not yet recruiting Efficacy and Safety Study of Pembrolizumab (MK-3475) in Women With Advanced Recurrent Ovarian Cancer (MK-3475-100/KEYNOTE-100)
Condition: Ovarian Neoplasms
Intervention: Biological: pembrolizumab
5 Recruiting Circadian Variation in Serum-progesterone Levels Following Controlled Ovarian Hyperstimulation.
Condition: Infertility
Intervention:
6 Recruiting Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Procedure: Hyperthermic intraperitoneal chemotherapy (HIPEC);   Drug: Carboplatin
7 Not yet recruiting MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors
Conditions: Non-Small Cell Lung Cancer;   Nonsmall Cell Lung Cancer;   Breast Cancer;   Cancer of Breast;   Cancer of the Breast;   Gastroesophageal Cancer;   Pancreatic Cancer;   Cancer of the Pancreas;   Colorectal Cancer;   Colorectal Carcinoma;   Renal Cancer;   Kidney Cancer;   Cancer of the Kidney;   Cancer of Kidney;   Ovarian Cancer;   Ovary Cancer;   Cancer of the Ovary;   Cancer of Ovary
Intervention: Drug: MEDI4736
8 Not yet recruiting LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer
Conditions: Epithelial Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer;   Gynaecological Malignancy
Intervention: Other: Diagnostic analysis
9 Not yet recruiting Study of the Isotopic Distribution of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian Origin
Condition: Ovarian Cancer
Intervention: Drug: Intraperitoneal cisplatin with nanocis
10 Not yet recruiting Effects of Alpha-acid Lipoic in PCOS Women
Condition: Polycystic Ovary Syndrome
Intervention: Drug: Alpha-lipoic acid
11 Recruiting Effects of Melatonin in PCOS Women
Condition: Polycystic Ovary Syndrome
Intervention: Drug: Melatonin
12 Not yet recruiting Anti-programmed Cell Death-1 Ligand 1 (PDL-1) Antibody Atezolizumab, Bevacizumab and Acetyl Salicylic Acid in Recurrent Platinum Resistant Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: Bevacizumab;   Drug: atezolizumab;   Drug: acetyl salicylic acid;   Drug: placebo
13 Not yet recruiting A Pilot Study of Induction Wee1 Inhibition in Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneum Cancer
Intervention: Drug: AZD1775
14 Not yet recruiting Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
Conditions: Small Cell Lung Carcinoma;   Carcinoma, Squamous Cell of Head and Neck;   Stomach Neoplasms;   Triple Negative Breast Neoplasms;   Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Peritoneal Neoplasms;   Esophagogastric Junction Neoplasms
Interventions: Drug: paclitaxel + carboplatin;   Drug: carboplatin + etoposide;   Drug: gemcitabine + carboplatin;   Drug: nab-paclitaxel (paclitaxel-albumin) + carboplatin;   Drug: oxaliplatin + 5-fluorouracil (5FU) + leucovorin (calcium folinate/folinic acid);   Biological: durvalumab;   Biological: tremelimumab
15 Not yet recruiting Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal or Endometrial Cancer
Conditions: Estrogen Receptor Positive;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Recurrent Uterine Corpus Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Drug: Ribociclib
16 Not yet recruiting Study of Niraparib in Combination With Pembrolizumab (MK-3475) in Patients With Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)
Conditions: Triple Negative Breast Cancer;   Ovarian Cancer;   Breast Cancer;   Metastatic Breast Cancer;   Advanced Breast Cancer;   Stage IV Breast Cancer;   Fallopian Tube Cancer;   Peritoneal Cancer
Interventions: Drug: niraparib;   Biological: pembrolizumab
17 Not yet recruiting Does Vitamin D Break the Vicious Circle of Polycystic Ovarian Syndrome of Insuline Resistance ?
Condition: PCOS
Interventions: Drug: Vitamin D;   Drug: placebo
18 Not yet recruiting A Study of Niraparib Maintenance Treatment in Patients With HRD-Positive Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
Condition: Ovarian Cancer
Interventions: Drug: Niraparib;   Drug: Placebo
19 Recruiting Sebum Excretion in Neonates of Women With Polycystic Ovary Syndrome (PCOS)
Condition: Polycystic Ovary Syndrome
Intervention: Other: Sebutape
20 Not yet recruiting Electroacupuncture on Hormonal and Glycometabolic Profiles in Women With Polycystic Ovary Syndrome: Study Protocol
Condition: Polycystic Ovary Syndrome
Interventions: Other: Acupuncture;   Other: Placebo-acupuncture group

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years